Milestone Pharmaceuticals (MIST) Earnings Date & Reports

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines... Show more

Industry: #Pharmaceuticals Major

Get AI intraday signals

A.I. Advisor

published Earnings

MIST is expected to report earnings to fall 6.65% to -18 cents per share on August 12

Milestone Pharmaceuticals MIST Stock Earnings Reports

Q2'26

Est.

$-0.19

Q1'26

Missed

by $0.43

Q4'25

Est.

$-0.16

Q3'25

Beat

by $0.04

Q2'25

Missed

by $0.02

The last earnings report on May 13 showed earnings per share of -20 cents, missing the estimate of 23 cents. With 687.44K shares outstanding, the current market capitalization sits at 158.11M.

View a ticker or compare two or three

Compare

MIST

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for MIST